PTPI — Petros Pharmaceuticals, Inc.
$0.00
+$0.00 (+0.00%)
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Market Cap
$127116.00
Forward P/E
-0.0x
52-Week Range
N/A
PTPI Price History
Revenue vs. Net Income
$5.8M
Revenue · FY2023
Annual. Net margin is shown under each year.
Free Cash Flow
-$7.6M
FCF · FY2023
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
-33.1%
ROCE · FY2023
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
1.6x
Assets ÷ liabilities · FY2023
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+5.1%
Dilution · FY2023
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
